drug · antibody
isatuximab
pre_registrationupdated 3mo agoby $SNY Sanofi🔗 ChEMBL
community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for neoplasm and multiple myeloma and 10 investigational indications.
targets
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
all catalysts(0)
nothing on the calendar yet
Trials studying isatuximab
- phase2Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
- phase2Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
- phase1A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- phase1Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma
- phase2Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia
- phase2KRDI in Transplant-Eligible MM
- phase2Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
- phase2Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
News(1)
- STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and moreU.S. health secretary Robert F. Kennedy Jr. is pressing forward with his effort to help Americans stop taking SSRI antidepressantsstat · 28d ago
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that